Insook Jang Selected Research

Obesity

11/2019	PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity.
9/2014	Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers.
9/2012	Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Insook Jang Research Topics

Disease

3	Obesity 11/2019 - 09/2012
2	Fatty Liver 01/2024 - 01/2021
2	Inflammation (Inflammations) 02/2016 - 09/2014
2	Neoplasms (Cancer) 02/2016 - 12/2009
2	Insulin Resistance 09/2014 - 09/2012
1	Hepatomegaly 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Glucose Intolerance 11/2019
1	Bites and Stings (Sting) 10/2018
1	Carcinogenesis 02/2016
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Colitis 02/2016
1	Hypertension (High Blood Pressure) 09/2014
1	Overnutrition 09/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2009
2	Insulin (Novolin)FDA Link 01/2021 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2009
2	Mechanistic Target of Rapamycin Complex 1IBA 02/2016 - 09/2012
1	VLDL LipoproteinsIBA 01/2024
1	LipidsIBA 01/2024
1	SynucleinsIBA 01/2021
1	ProinsulinIBA 11/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2018
1	InterferonsIBA 10/2018
1	SestrinsIBA 02/2016
1	CalciumIBA 09/2014
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2014
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2012
1	TOR Serine-Threonine KinasesIBA 09/2012
1	Adenosine Triphosphate (ATP)IBA 12/2009
1	GlycogenIBA 12/2009